BWP
FLGT icon

Baldwin Wealth Partners’s Fulgent Genetics FLGT Stock Holding History

Baldwin Wealth Partners’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,000
Closed -$38K – 794
2022
Q3 		$38K Hold
1,000
– – 0.01% 361
2022
Q2 		$55K Sell
1,000
-400
-29% -$22K 0.01% 341
2022
Q1 		$87K Buy
1,400
+400
+40% +$26.3K 0.01% 289
2021
Q4 		$101K Hold
1,000
– – 0.01% 264
2021
Q3 		$90K Hold
1,000
– – 0.01% 275
2021
Q2 		$92K Hold
1,000
– – 0.01% 279
2021
Q1 		$97K Buy
+1,000
New +$103K 0.01% 260

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Baldwin Wealth Partners's FLGT Position: Q4 2022 in Review

Baldwin Wealth Partners sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 1,000 shares — an estimated $38K sold.

Baldwin Wealth Partners first reported a position in FLGT in Q1 2021 and held it in 7 quarters. The position peaked at $101K in Q4 2021. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • Baldwin Wealth Partners reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
  • Baldwin Wealth Partners sold 1,000 Fulgent Genetics shares in Q4 2022, an estimated $38K.
  • Baldwin Wealth Partners first reported a position in Fulgent Genetics in Q1 2021 and held it in 7 quarters.
  • Baldwin Wealth Partners's Fulgent Genetics position peaked at $101K in Q4 2021.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on Baldwin Wealth Partners's 13F filing for Q4 2022, filed 27 Jan 2023.